相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society Survey
Konstantinos C. Koskinas et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)
Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects
Yani Yu et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
Kausik K. Ray et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome
Qinqin Wang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool
Alessandro Sionis et al.
ATHEROSCLEROSIS SUPPLEMENTS (2020)
Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives
Marco Alings et al.
ATHEROSCLEROSIS SUPPLEMENTS (2020)
Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project
Ulf Landmesser et al.
ATHEROSCLEROSIS SUPPLEMENTS (2020)
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
Guy De Backer et al.
ATHEROSCLEROSIS (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins
Kathleen M. Fox et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review
Saga Johansson et al.
BMC CARDIOVASCULAR DISORDERS (2017)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano et al.
EUROPEAN HEART JOURNAL (2016)
The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS)
Bernhard Rauch et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
分享论文
